• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用包埋在玻璃纤维凝胶柱中的多克隆抗体从荷结肠肿瘤大鼠血清中分离肿瘤相关蛋白。

Isolation of tumor-associated protein from sera of colon tumor-bearing rats using polyclonal antibodies entrapped in gel fiberglass columns.

作者信息

Zusman I, Zusman R, Korol D

出版信息

Oncol Rep. 1994 Jul;1(4):751-4. doi: 10.3892/or.1.4.751.

DOI:10.3892/or.1.4.751
PMID:21607435
Abstract

A new, effective support for the isolation of proteins has been invented utilizing a gel fiberglass (GFG) (R. Zusman, Patent application 1992, 1993). We describe the utilization of this support to isolate tumor-associated proteins (TAP) from sera of colon tumor-bearing rats. Sera were percolated through GFG columns with entrapped anti-rat colon cancer IgG from rabbits. TAP were eluted in a large amount, up to 3 mg/ml sera/column. Their affinity to antitumorous polyclonal antibodies was detected by ELISA. Western immunoblotting with commercial monoclonal antibodies has identified the isolated antigens as p21 and p53. Their concentrations were much higher (up to 1,000 times) in sera from tumor-bearing rats compared to control rats. The method was highly reproducible. It is suggested that data obtained can be considered as a basis for the further improving of quantitative methods of diagnosis.

摘要

利用凝胶玻璃纤维(GFG)发明了一种用于蛋白质分离的新型有效载体(R. 祖斯曼,专利申请,1992年,1993年)。我们描述了利用这种载体从荷瘤大鼠血清中分离肿瘤相关蛋白(TAP)的方法。血清通过装有兔抗大鼠结肠癌IgG的GFG柱进行渗滤。大量TAP被洗脱出来,每毫升血清/柱可达3毫克。通过ELISA检测它们与抗肿瘤多克隆抗体的亲和力。用商业单克隆抗体进行的Western免疫印迹法已将分离出的抗原鉴定为p21和p53。与对照大鼠相比,荷瘤大鼠血清中它们的浓度要高得多(高达1000倍)。该方法具有高度可重复性。建议所获得的数据可作为进一步改进定量诊断方法的基础。

相似文献

1
Isolation of tumor-associated protein from sera of colon tumor-bearing rats using polyclonal antibodies entrapped in gel fiberglass columns.使用包埋在玻璃纤维凝胶柱中的多克隆抗体从荷结肠肿瘤大鼠血清中分离肿瘤相关蛋白。
Oncol Rep. 1994 Jul;1(4):751-4. doi: 10.3892/or.1.4.751.
2
Isolation of p53 protein from the serum of colon-cancer and noncancer patients.从结肠癌和非癌症患者的血清中分离 p53 蛋白。
Oncol Rep. 1995 Jul;2(4):679-83. doi: 10.3892/or.2.4.679.
3
Gel fiberglass as a new matrix of affinity chromatography columns for isolation of colon cancer-associated antigens.凝胶玻璃纤维作为亲和层析柱的新型基质用于分离结肠癌相关抗原。
Int J Oncol. 1996 Jul;9(1):153-7.
4
The role of the soluble p53 antigen and its autoantibodies as markers for diagnosis of colon cancer: a comparative study.可溶性p53抗原及其自身抗体作为结肠癌诊断标志物的作用:一项比较研究。
Int J Mol Med. 1998 Feb;1(2):453-7. doi: 10.3892/ijmm.1.2.453.
5
Specificity of polyclonal anti-p53 IgG for isolation of the soluble p53 antigen from human serum.用于从人血清中分离可溶性p53抗原的多克隆抗p53 IgG的特异性。
Int J Mol Med. 1998 Apr;1(4):767-70. doi: 10.3892/ijmm.1.4.767.
6
Gel fiberglass membranes for affinity chromatography columns and their application to cancer detection.用于亲和色谱柱的凝胶玻璃纤维膜及其在癌症检测中的应用。
J Chromatogr B Biomed Sci Appl. 1998 Sep 11;715(1):297-306. doi: 10.1016/s0378-4347(98)00022-x.
7
IgG generated against benign tumor-associated antigens prevented the effects of 1,2-dimethylhydrazine in rats.针对良性肿瘤相关抗原产生的免疫球蛋白G可预防二甲基肼对大鼠的影响。
Anticancer Res. 1996 May-Jun;16(3A):1183-6.
8
High tumor-preventive effects of polyclonal IgG generated against p53 tumor-associated protein obtained from benign-tumor bearing rats.从携带良性肿瘤的大鼠中获得的针对p53肿瘤相关蛋白产生的多克隆IgG具有高度的肿瘤预防作用。
Oncol Rep. 1996 Sep;3(5):975-9. doi: 10.3892/or.3.5.975.
9
Glass fibers covered with sol-gel glass as a new support for affinity chromatography columns: a review.覆盖有溶胶-凝胶玻璃的玻璃纤维作为亲和色谱柱的新型载体:综述
J Biochem Biophys Methods. 2001 Oct 30;49(1-3):175-87. doi: 10.1016/s0165-022x(01)00198-1.
10
Expression of p53 protein in rat colon cancer cell lines transfected with Rous sarcoma virus-33.用劳斯肉瘤病毒-33转染的大鼠结肠癌细胞系中p53蛋白的表达
Cancer Lett. 1997 Dec 23;121(2):133-7. doi: 10.1016/s0304-3835(97)00345-5.